174 related articles for article (PubMed ID: 34059348)
21. Light-enhanced cognitive behavioural therapy for sleep and fatigue: study protocol for a randomised controlled trial during chemotherapy for breast cancer.
Bean HR; Stafford L; Little R; Diggens J; Ftanou M; Alexander M; Francis PA; Bei B; Wiley JF
Trials; 2020 Mar; 21(1):295. PubMed ID: 32216832
[TBL] [Abstract][Full Text] [Related]
22. Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial.
Richards DA; Ekers D; McMillan D; Taylor RS; Byford S; Warren FC; Barrett B; Farrand PA; Gilbody S; Kuyken W; O'Mahen H; Watkins ER; Wright KA; Hollon SD; Reed N; Rhodes S; Fletcher E; Finning K
Lancet; 2016 Aug; 388(10047):871-80. PubMed ID: 27461440
[TBL] [Abstract][Full Text] [Related]
23. Fear of progression in patients 6 months after cancer rehabilitation-a- validation study of the fear of progression questionnaire FoP-Q-12.
Hinz A; Mehnert A; Ernst J; Herschbach P; Schulte T
Support Care Cancer; 2015 Jun; 23(6):1579-87. PubMed ID: 25412727
[TBL] [Abstract][Full Text] [Related]
24. Personalized versus standard cognitive behavioral therapy for fear of cancer recurrence, depressive symptoms or cancer-related fatigue in cancer survivors: study protocol of a randomized controlled trial (MATCH-study).
Harnas SJ; Knoop H; Bennebroek Evertsz F; Booij SH; Dekker J; van Laarhoven HWM; van der Lee M; Meijer E; Sharpe L; Sprangers MAG; van Straten A; Zweegman S; Braamse AMJ
Trials; 2021 Oct; 22(1):696. PubMed ID: 34641961
[TBL] [Abstract][Full Text] [Related]
25. Validation of the Portuguese Version of the Fear of Progression Questionnaire-Short Form (FoP-Q-SF) in Portuguese Cancer Survivors.
Silva S; Bártolo A; Santos IM; Paiva D; Monteiro S
Healthcare (Basel); 2022 Dec; 10(12):. PubMed ID: 36553990
[TBL] [Abstract][Full Text] [Related]
26. Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapy.
Friedlander M; Rau J; Lee CK; Meier W; Lesoin A; Kim JW; Poveda A; Buck M; Scambia G; Shimada M; Hilpert F; King MT; Debruyne P; Bologna A; Malander S; Monk BJ; Petru E; Calvert P; Herzog TJ; Barrett C; du Bois A
Ann Oncol; 2018 Mar; 29(3):737-743. PubMed ID: 29267856
[TBL] [Abstract][Full Text] [Related]
27. Fear of cancer recurrence across the survivorship trajectory: Results from a survey of adult long-term cancer survivors.
Götze H; Taubenheim S; Dietz A; Lordick F; Mehnert-Theuerkauf A
Psychooncology; 2019 Oct; 28(10):2033-2041. PubMed ID: 31364222
[TBL] [Abstract][Full Text] [Related]
28. Effects of nurse-led home-based exercise & cognitive behavioral therapy on reducing cancer-related fatigue in patients with ovarian cancer during and after chemotherapy: A randomized controlled trial.
Zhang Q; Li F; Zhang H; Yu X; Cong Y
Int J Nurs Stud; 2018 Feb; 78():52-60. PubMed ID: 28939343
[TBL] [Abstract][Full Text] [Related]
29. Marital Self-Disclosure Intervention for the Fear of Cancer Recurrence in Chinese Patients With Gastric Cancer: Protocol for a Quasiexperimental Study.
Zhao H; Zhou Y; Che CC; Chong MC; Zheng Y; Hou Y; Chen C; Zhu Y
JMIR Res Protoc; 2024 Apr; 13():e55102. PubMed ID: 38684089
[TBL] [Abstract][Full Text] [Related]
30. Effects of a Sound Intervention on Physical and Emotional Well-Being in Patients with Cancer: A Prospective Randomized Trial.
Hohneck A; Meissner R; Reyser C; Heinemann L; Christians K; Merx K; Weingärtner S; Mavratzas A; Schulte N; Burkholder I; Hofmann WK; Hofheinz RD
Oncol Res Treat; 2023; 46(1-2):1-10. PubMed ID: 36657417
[TBL] [Abstract][Full Text] [Related]
31. Randomized study of sequential cisplatin-topotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of life.
Brotto L; Brundage M; Hoskins P; Vergote I; Cervantes A; Casado HA; Poveda A; Eisenhauer E; Tu D; ; ;
Support Care Cancer; 2016 Mar; 24(3):1241-9. PubMed ID: 26304156
[TBL] [Abstract][Full Text] [Related]
32. Controlled trial of the impact of a BC adult mental health practice support program (AMHPSP) on primary health care professionals' management of depression.
Lauria-Horner B; Beaulieu T; Knaak S; Weinerman R; Campbell H; Patten S
BMC Fam Pract; 2018 Nov; 19(1):183. PubMed ID: 30486799
[TBL] [Abstract][Full Text] [Related]
33. The Feasibility and Effects of Acupuncture on Quality of Life Scores During Chemotherapy in Ovarian Cancer: Results from a Pilot, Randomized Sham-Controlled Trial.
Lu W; Matulonis UA; Dunn JE; Lee H; Doherty-Gilman A; Dean-Clower E; Goodman A; Davis RB; Buring J; Wayne P; Rosenthal DS; Penson RT
Med Acupunct; 2012 Dec; 24(4):233-240. PubMed ID: 24761165
[TBL] [Abstract][Full Text] [Related]
34. When will I feel normal again? Trajectories and predictors of persistent symptoms and poor wellbeing after primary chemotherapy for ovarian cancer.
Beesley VL; Webber K; Nagle CM; DeFazio A; Obermair A; Williams M; Friedlander M; Webb PM;
Gynecol Oncol; 2020 Oct; 159(1):179-186. PubMed ID: 32773150
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of Three Low-Intensity, Internet-Based Psychological Interventions for the Treatment of Depression in Primary Care: Randomized Controlled Trial.
Gili M; Castro A; García-Palacios A; Garcia-Campayo J; Mayoral-Cleries F; Botella C; Roca M; Barceló-Soler A; Hurtado MM; Navarro M; Villena A; Pérez-Ara MÁ; Riera-Serra P; Baños RM
J Med Internet Res; 2020 Jun; 22(6):e15845. PubMed ID: 32501276
[TBL] [Abstract][Full Text] [Related]
36. Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme.
O'Dowd H; Gladwell P; Rogers CA; Hollinghurst S; Gregory A
Health Technol Assess; 2006 Oct; 10(37):iii-iv, ix-x, 1-121. PubMed ID: 17014748
[TBL] [Abstract][Full Text] [Related]
37. Cost and Effectiveness of Blended Versus Standard Cognitive Behavioral Therapy for Outpatients With Depression in Routine Specialized Mental Health Care: Pilot Randomized Controlled Trial.
Kooistra LC; Wiersma JE; Ruwaard J; Neijenhuijs K; Lokkerbol J; van Oppen P; Smit F; Riper H
J Med Internet Res; 2019 Oct; 21(10):e14261. PubMed ID: 31663855
[TBL] [Abstract][Full Text] [Related]
38. Health-related quality of life after interval cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with stage III ovarian cancer.
Koole SN; Kieffer JM; K Sikorska ; Schagen van Leeuwen JH; Schreuder HWR; Hermans RH; de Hingh IH; van der Velden J; Arts HJ; van Ham MAPC; Aalbers AG; Verwaal VJ; Van de Vijver KK; Sonke GS; van Driel WJ; Aaronson NK
Eur J Surg Oncol; 2021 Jan; 47(1):101-107. PubMed ID: 31128948
[TBL] [Abstract][Full Text] [Related]
39. Group cognitive behavioural therapy for women with depression: pilot and feasibility study for a randomised controlled trial using mixed methods.
Cramer H; Salisbury C; Conrad J; Eldred J; Araya R
BMC Psychiatry; 2011 May; 11():82. PubMed ID: 21569488
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial.
Groenvold M; Fayers PM; Petersen MA; Mouridsen HT
Breast Cancer Res Treat; 2006 Aug; 98(3):275-84. PubMed ID: 16541325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
